{"name":"Mitos Pharmaceuticals","slug":"mitos-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNSjdLU09iNlh6TGFXSjN6XzFDWkJzcDB4RGdieHhZbUZHQWV2S3pDRDVUMXJvTFhsOXEyZ0tnYzItbndKR3RoNC13MTRDbTlaRkdvMVNEVzZPOURic1B3cUJSRDRzMmY5U3ZHM3R4Z2xycHpVWkgxdVFNTnlCVGNPdTZUeU1GNi1scnNnRkhRbVhWNnZRU29BNmJkbHgzTm5YdHZ4ZlVfUWVacFU5Q3JxNmtjWjJaVmh0cG9TQWVRM2hzQmw0WUJWMUJpLTNSOElobUdPV2ZYa1ZNbTVta0FVZWh6OA?oc=5","date":"2017-05-17","type":"pipeline","source":"European Pharmaceutical Review","summary":"Dolomite Microfluidics’ Mitos P-Pumps enable reliable production of highly monodisperse droplets - European Pharmaceutical Review","headline":"Dolomite Microfluidics’ Mitos P-Pumps enable reliable production of highly monodisperse droplets","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}